Zweig-DiMenna Associates’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-300,000
Closed -$5.05M 120
2022
Q4
$5.05M Buy
+300,000
New +$4.95M 0.74% 51

Other funds holding PTEN

Zweig-DiMenna Associates's PTEN Position: Q1 2023 in Review

Zweig-DiMenna Associates sold out of Patterson-UTI (PTEN) in Q1 2023, closing a stake of 253,000 shares — an estimated $4.26M sold.

Zweig-DiMenna Associates first reported a position in PTEN in Q2 2013 and held it in 5 quarters. The position peaked at $11M in Q3 2014. 285 funds tracked by Wall St. Rank hold PTEN as of Q1 2023.

  • Zweig-DiMenna Associates reported no remaining Patterson-UTI position as of Q1 2023 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 253,000 Patterson-UTI shares in Q1 2023, an estimated $4.26M.
  • Zweig-DiMenna Associates first reported a position in Patterson-UTI in Q2 2013 and held it in 5 quarters.
  • Zweig-DiMenna Associates's Patterson-UTI position peaked at $11M in Q3 2014.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2023.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2023, filed 28 Apr 2023.